Compare CADL & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | NATH |
|---|---|---|
| Founded | 1999 | 1916 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.4M | 411.7M |
| IPO Year | 2021 | 1996 |
| Metric | CADL | NATH |
|---|---|---|
| Price | $4.91 | $100.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $19.71 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 20.4K |
| Earning Date | 03-12-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 1.98% |
| EPS Growth | ★ 58.62 | 22.29 |
| EPS | N/A | ★ 4.17 |
| Revenue | $125,000.00 | ★ $104,201,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $24.18 |
| Revenue Growth | N/A | ★ 7.81 |
| 52 Week Low | $4.25 | $88.00 |
| 52 Week High | $7.24 | $118.32 |
| Indicator | CADL | NATH |
|---|---|---|
| Relative Strength Index (RSI) | 47.72 | 54.64 |
| Support Level | $4.58 | $100.25 |
| Resistance Level | $5.42 | $102.05 |
| Average True Range (ATR) | 0.26 | 0.36 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 61.42 | 62.67 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.